CD8A and neoplasm: On the other hand, Th17 may contribute to protective tumor immunity via stimulating the production of Th1 chemokines CXCL9 and CXCL10 to recruit effector cells to tumor tissues44 and to elicit the activation of tumor-specific CD8+ T cells45.